Speakers

David Sourdive

Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis

David Sourdive, Ph.D, is a co-founder of Cellectis and joined the Board of Directors in 2000. Dr. Sourdive combines a strong scientific expertise with experience in managing industrial programs bringing innovative technologies to industrial fruition. He served as Executive Vice President, Corporate Development, from 2008 to 2016 and as Executive Vice President, Technical Operations until July, 2019. In addition to his role at Cellectis, Dr. Sourdive has also served on the board of directors of the Mediterranean Institute for Life Sciences. David Sourdive graduated from École Polytechnique, received his Ph.D. in molecular virology at Institut Pasteur and completed a research fellowship in the Emory University Department of Microbiology and Immunology. His management training is from the HEC (Challenge +) and his decade-long experience in industrial program management was acquired at the French Department of Defense (DGA) prior to Cellectis’ inception.

Also Speaking

Ryan Saadi

Founder, Chair and Chief Executive Officer • Tevogen

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Lisa Deschamps

Chief Executive Officer • AviadoBio

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.